TickerFacts.

Aclarion, Inc. (ACON): Operating Income

Annual figures by period end, from SEC filings.

-$7.05M
Year ended 2025-12-31
-$9.71M
Trailing 12 months to 2026-06-30
2021-12-31: -$2.95M2022-12-31: -$5.56M2023-12-31: -$4.88M2024-12-31: -$5.51M2025-12-31: -$7.05M-$7.05M
2021-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$7.05Mn/m2026-03-18, From 2025-01-01
2024-12-31-$5.51Mn/m2026-03-18, From 2024-01-01
2023-12-31-$4.88Mn/m2025-04-09, From 2023-01-01
2022-12-31-$5.56Mn/m2024-03-28, From 2022-01-01
2021-12-31-$2.95Mn/a2023-06-12, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Aclarion, Inc. (ACON)2025-12-31-$7.05Mn/m
Sera Prognostics, Inc. (SERA)2025-12-31-$36.50Mn/m
YD Bio Ltd (YDES)2025-12-31-$5.27Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31-$2.97Mn/m
American Shared Hospital Services (AMS)2025-12-31-$3.59Mn/m
CapForce Inc. (CFOR)2025-12-31$24.03Mn/m
Exagen Inc. (XGN)2025-12-31-$14.07Mn/m
Personalis, Inc. (PSNL)2025-12-31-$88.06Mn/m
Biodesix Inc (BDSX)2025-12-31-$27.87Mn/m

Compare ACON, SERA, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗